Manipal Health FY26 Financials: Revenue at Rs 10,336 Crore

Operating EBITDA stood at Rs 2,644 crore, with a profit for the year of Rs 917 crore.

Reader Takeaway: Strong revenue growth and hospital network expansion driven by key acquisitions like Sahyadri Hospitals.

What just happened

Manipal Health Enterprises has announced its financial results for the 2025-26 fiscal year, showcasing substantial growth in both top-line revenue and patient volume. Revenue climbed 25.4% year-on-year, reaching Rs 10,336 crore, while operating EBITDA margins were reported at 25.6%. The company successfully integrated the Sahyadri Hospitals network and opened two new greenfield facilities in Bengaluru.

Why this matters

The results highlight the scale of Manipal Health’s aggressive expansion strategy. By increasing its total licensed bed capacity to over 13,000 across 49 hospitals, the company is solidifying its footprint as a leading healthcare provider in India. Efficiency metrics have also improved, with the average length of stay dropping to 2.8 days.

Business and Governance Updates

Shareholders approved a series of resolutions, including the adoption of consolidated financial statements and the appointment of Price Waterhouse as statutory auditors for five years. Furthermore, the company greenlit the 'ESOP 2024 Plan' and formalised amendments to its Articles of Association regarding special rights for major stakeholders, including the Temasek and MGHS groups.

What to track next

Investors should monitor the integration of the Sahyadri acquisition and the ramp-up of the new greenfield facilities in Bengaluru. The long-term impact of the new ESOP plan and the performance of high-acuity specialties—which currently contribute over 64% of gross inpatient revenue—will be critical indicators for future profitability.